MicroRNA: Potential targets for the development of novel drugs?

Drugs in R and D

Volumn 10, Issue 1, 2010, Pages 1-8

  Wu, Wei ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

general; Genetic Therapy; MicroRNAs; RNA; RNA target

Indexed keywords

CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; LOCKED NUCLEIC ACID; MESSENGER RNA; MICRORNA; MICRORNA 16; MICRORNA 26A; MICRORNA LET 7; MICRORNA LET 7A; MICRORNA LET 7G; MIRAVIRSEN; TAMOXIFEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL RENEWAL; DRUG SENSITIVITY; EPIGENETICS; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INTERACTION; GENE MUTATION; HUMAN; METASTASIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; ONCOGENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; DRUG DISCOVERY; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; NEOPLASMS;

EID: 79953185385     PISSN: 11745886     EISSN: 11796901     Source Type: Journal    
DOI: 10.2165/11537800-000000000-00000     Document Type: Article

References (60)

1. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003;113:673-6 (Pubitemid 36724931)
2. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8 (Pubitemid 40839735)
3. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-66 (Pubitemid 44629897)
4. Wang V, Wu W. MicroRNA-based therapeutics for cancer. BioDrugs 2009;23:15-23
5. Kim VN, Nam JW. Genomics of microRNA. Trends Genet 2006 Mar; 22(3):165-73 (Pubitemid 43290020)
6. Lytle JR, Yario TA, Steitz JA. Target mRNAs are repressed as efficiently bymicroRNA-binding sites in the 50 UTRas in the 30 UTR. Proc Natl Acad Sci U S A 2007;104:9667-72 (Pubitemid 47175324)
7. Qin W, Shi Y, Zhao B, et al. miR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells. PLoS One 2010;5: e9429
8. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007;318:1931-4
9. Zhang L, Huang J, Yang N, et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 2006;103:9136-41 (Pubitemid 43902545)
10. Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65(21):9628-32 (Pubitemid 41541436)
11. Ota A, Tagawa H, Karnan S, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 2004;64:3087-95 (Pubitemid 38581408)
12. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-9 (Pubitemid 35403967)
13. Scott GK, Mattie MD, Berger CE, et al. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 2006;66:1277-81 (Pubitemid 43259904)
14. Lujambio A, Ropero S, Ballestar E, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007;67:1424-9 (Pubitemid 46383366)
15. Saito Y, Liang G, Egger G, et al. Specific activation ofmicro-RNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006;9:435-43 (Pubitemid 43832188)
16. O'Donnell KA, Wentzel EA, Zeller KI, et al. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005;435:839-43 (Pubitemid 40839736)
17. Chang TC, Wentzel EA, Kent OA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007;26:745-52 (Pubitemid 46856245)
18. Wu W, Sun M, Zou GM, et al. MicroRNA and cancer: current status and prospective. Int J Cancer 2007;120(5):953-60 (Pubitemid 46214293)
19. Winter J, Jung S, Keller S, et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009;11:228-34
20. Xiao J, Yang B, Lin H, et al. Novel approaches for genespecific interference via manipulating actions of micro-RNAs: examination on the pacemaker channel genes HCN2 and HCN4. J Cell Physiol 2007;212:285-92 (Pubitemid 47025616)
21. Lu Y, Xiao J, Lin H, et al. A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Res 2009;37: e24
22. Gumireddy K, Young DD, Xiong X, et al. Small-molecule inhibitors of microRNA miR-21 function. Angew Chem Int Ed Engl 2008;47:7482-4
23. Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009;37:918-25
24. Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007;133(2):647-58 (Pubitemid 47187346)
25. Zhu S, Si ML, Wu H, et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007;282(19):14328-36 (Pubitemid 47100416)
26. Frankel LB, Christoffersen NR, Jacobsen A, et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008;283(2):1026-33
27. Bottoni A, Piccin D, Tagliati F, et al. miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 2005;204:280-5 (Pubitemid 40776831)
28. Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753-6 (Pubitemid 38697282)
29. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005;102:13944-9 (Pubitemid 41377683)
30. Johnson CD, Esquela-Kerscher A, Stefani G, et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007;67:7713-22 (Pubitemid 47281364)
31. Nakano H, Miyazawa T, Kinoshita K, et al. Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X (L) in colorectal cancer cells. Int J Cancer. Epub 2009 Dec. 28
32. Frank NY, Schatton T, Frank MH. The therapeutic promise of the cancer stem cell concept. J Clin Invest 2010;120(1):41-50
33. Zhao JJ, Lin J, Yang H, et al. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 2008;283:31079-86
34. Liang Z, Wu H, Xia J, et al. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 2010;79:817-24
35. Gupta PB, Onder TT, Jiang G, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009;138(4):645-59
36. Wang V, Wu W. MicroRNA: a new player in breast cancer development. J Cancer Mol 2007;3:133-8
37. Yu F, Yao H, Zhu P, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007;131:1109-23 (Pubitemid 350235025)
38. Shimono Y, Zabala M, Cho RW, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009;138:592-603
39. Taulli R, Bersani F, Foglizzo V, et al. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 2009;119:2366-78
40. Heneghan HM, Miller N, Lowery AJ, et al. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010;251:499-505
41. Hu Z, Chen X, Zhao Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010;28(10):1721-6
42. Gee HE, Camps C, Buffa FM, et al. hsa-miR-210 is amarker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010;116(9):2148-58
43. Mishra PJ, Humeniuk R, Longo-Sorbello GS, et al. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci U S A 2007;104:13513-8 (Pubitemid 47293976)
44. Lewis BP, Shih IH, Jones-Rhoades MW, et al. Prediction of mammalian microRNA targets. Cell 2003;115:787-98 (Pubitemid 38058492)
45. Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19(1):92-105
46. Miranda KC, Huynh T, Tay Y, et al. A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 2006;126:1203-17 (Pubitemid 44380294)
47. Ivanovska I, Cleary MA. Combinatorial microRNAs: working together to make a difference. Cell Cycle 2008;7:3137-42
48. Ruby JG, Jan C, Player C, et al. Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell 2006;127:1193-207 (Pubitemid 44894525)
49. Sotiropoulou G, Pampalakis G, Lianidou E, et al. Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA 2009;15:1443-61
50. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007;4:721-6 (Pubitemid 47338166)
51. Si ML, Zhu S, Wu H, et al. miR-21-mediated tumor growth. Oncogene 2007;26(19):2799-803 (Pubitemid 46663837)
52. Park SM, Shell S, Radjabi AR, et al. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 2007;6:2585-90 (Pubitemid 350224037)
53. Takeshita F, Patrawala L, Osaki M, et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cellcycle genes. Mol Ther 2010;18:181-7
54. Esquela-Kerscher A, Trang P, Wiggins JF, et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 2008;7:759-64 (Pubitemid 351520040)
55. Kumar MS, Erkeland SJ, Pester RE, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A 2008;105:3903-8 (Pubitemid 351723497)
56. Trang P, Medina PP, Wiggins JF, et al. Regression of murine lung tumors by the let-7 microRNA. Oncogene 2010;29(11):1580-7
57. Kota J, Chivukula RR, O'Donnell KA, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009;137:1005-17
58. Stenvang J, Lindow M, Kauppinen S. Targeting of microRNAs for therapeutics. Biochem Soc Trans 2008;36(Pt 6):1197-200
59. Elmén J, Lindow M, Schütz S, et al. LNA-mediated micro-RNA silencing in non-human primates. Nature 2008;452(7189):896-9 (Pubitemid 351550859)
60. Santaris Pharma begins human clinical testing of the world's first medicine targeted at a human microRNA [media release]. 2008 May 28 [online] Available from URL: http://www.fier cebiotech.com/press-releases/santaris- pharma-begins-humanclinicaltesting-worlds-first-medicine-targeted-human-mi